LFMD Q3 2022 Earnings — LifeMD, Inc. Revenue & Financial Results | Market Cap Arena

LFMDLifeMD, Inc.

$200M

Q3 2022 Earnings

Healthcare Medical - Pharmaceuticals

Income Statement

Revenue

$31M+25.9% YoY

Gross Profit

$27M85.0% margin

Operating Income

-$7M-22.5% margin

Net Income

-$7M-23.2% margin

EPS (Diluted)

$-0.27

QoQ Revenue Growth

+3.1%

Cash Flow

Operating Cash Flow

-$3M

Free Cash Flow

-$5M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$33M

Total Liabilities

$30M

Stockholders' Equity

$4M

Cash & Equivalents

$6M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$31M	$25M	+25.9%
Gross Profit	$27M	$20M	+34.5%
Operating Income	-$7M	-$13M	+43.9%
Net Income	-$7M	-$14M	+49.3%